Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Virology

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    August 2018
  1. GIULIANI E, Vassena L, Galardi S, Michienzi A, et al
    Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
    Virology. 2018;523:121-128.
    PubMed     Text format     Abstract available


  2. MEIER K, Jaguva Vasudevan AA, Zhang Z, Bahr A, et al
    Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).
    Virology. 2018;523:52-63.
    PubMed     Text format     Abstract available


  3. NUNES JM, Furtado MN, de Morais Nunes ER, Sucupira MCA, et al
    Modulation of epigenetic factors during the early stages of HIV-1 infection in CD4(+) T cells in vitro.
    Virology. 2018;523:41-51.
    PubMed     Text format     Abstract available


    July 2018
  4. SELYUTINA A, Bulnes-Ramos A, Diaz-Griffero F
    Binding of host factors to stabilized HIV-1 capsid tubes.
    Virology. 2018;523:1-5.
    PubMed     Text format     Abstract available


  5. LIU H, Hu PW, Couturier J, Lewis DE, et al
    HIV-1 replication in CD4(+) T cells exploits the down-regulation of antiviral NEAT1 long non-coding RNAs following T cell activation.
    Virology. 2018;522:193-198.
    PubMed     Text format     Abstract available


  6. JAGUVA VASUDEVAN AA, Bahr A, Grothmann R, Singer A, et al
    MXB inhibits murine cytomegalovirus.
    Virology. 2018;522:158-167.
    PubMed     Text format     Abstract available


    June 2018
  7. GUO J, Liu X, Wu C, Hu J, et al
    The transmembrane nucleoporin Pom121 ensures efficient HIV-1 pre-integration complex nuclear import.
    Virology. 2018;521:169-174.
    PubMed     Text format     Abstract available


  8. BOWDER D, Hollingsead H, Durst K, Hu D, et al
    Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses.
    Virology. 2018;521:158-168.
    PubMed     Text format     Abstract available


  9. HONG F, Jacobs JL, Aga E, Cillo AR, et al
    Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy.
    Virology. 2018;521:51-57.
    PubMed     Text format     Abstract available


  10. TIMILSINA U, Ghimire D, Adhikari LP, Bhattarai A, et al
    Maturation inhibitors facilitate virus assembly and release of HIV-1 capsid P224 mutant.
    Virology. 2018;521:44-50.
    PubMed     Text format     Abstract available


    May 2018
  11. MEFFERD AL, Bogerd HP, Irwan ID, Cullen BR, et al
    Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.
    Virology. 2018;520:116-126.
    PubMed     Text format     Abstract available


  12. MARSDEN MD, Wu X, Navab SM, Loy BA, et al
    Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
    Virology. 2018;520:83-93.
    PubMed     Text format     Abstract available


  13. BOWDER D, Thompson J, Durst K, Hollingsead H, et al
    Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses.
    Virology. 2018;519:180-189.
    PubMed     Text format     Abstract available


    April 2018
  14. BOLIAR S, Patil S, Shukla BN, Ghobbeh A, et al
    Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category.
    Virology. 2018;519:99-105.
    PubMed     Text format     Abstract available


    March 2018
  15. ZHANG Y, Lu J, Liu X
    MARCH2 is upregulated in HIV-1 infection and inhibits HIV-1 production through envelope protein translocation or degradation.
    Virology. 2018;518:293-300.
    PubMed     Text format     Abstract available


  16. BARKLIS E, Staubus AO, Mack A, Harper L, et al
    Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins.
    Virology. 2018;518:264-271.
    PubMed     Text format     Abstract available


  17. MELTZER B, Dabbagh D, Guo J, Kashanchi F, et al
    Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.
    Virology. 2018;518:241-252.
    PubMed     Text format     Abstract available


    February 2018
  18. DEBOER J, Wojtkiewicz MS, Haverland N, Li Y, et al
    Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry.
    Virology. 2018;516:246-257.
    PubMed     Text format     Abstract available


  19. KHAN AS, Bodem J, Buseyne F, Gessain A, et al
    Spumaretroviruses: Updated taxonomy and nomenclature.
    Virology. 2018;516:158-164.
    PubMed     Text format     Abstract available


    January 2018
  20. SERTZNIG H, Hillebrand F, Erkelenz S, Schaal H, et al
    Behind the scenes of HIV-1 replication: Alternative splicing as the dependency factor on the quiet.
    Virology. 2018;516:176-188.
    PubMed     Text format     Abstract available


  21. ZHANG M, Robinson TO, Duverger A, Kutsch O, et al
    Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins.
    Virology. 2018;516:21-29.
    PubMed     Text format     Abstract available


  22. CHUA BA, Ngo JA, Situ K, Ramirez CM, et al
    Protein S and Gas6 induce efferocytosis of HIV-1-infected cells.
    Virology. 2018;515:176-190.
    PubMed     Text format     Abstract available


    December 2017
  23. YASEN A, Herrera R, Rosbe K, Lien K, et al
    HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles.
    Virology. 2017;515:92-107.
    PubMed     Text format     Abstract available


  24. SCHULTE B, Selyutina A, Opp S, Herschhorn A, et al
    Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.
    Virology. 2017;515:52-65.
    PubMed     Text format     Abstract available


  25. PREVOST J, Richard J, Ding S, Pacheco B, et al
    Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals.
    Virology. 2017;515:38-45.
    PubMed     Text format     Abstract available


    November 2017
  26. HOGAN MJ, Conde-Motter A, Jordan APO, Yang L, et al
    Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization.
    Virology. 2017;514:106-117.
    PubMed     Text format     Abstract available


  27. LIU Y, Chen J, Nikolaitchik OA, Desimmie BA, et al
    The roles of five conserved lentiviral RNA structures in HIV-1 replication.
    Virology. 2017;514:1-8.
    PubMed     Text format     Abstract available


    October 2017
  28. DIAZ F, Gregory S, Nakashima H, Viapiano MS, et al
    Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.
    Virology. 2017;513:129-135.
    PubMed     Text format     Abstract available


  29. SCHWARTZ EJ, Vaidya NK, Dorman KS, Carpenter S, et al
    Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses.
    Virology. 2017;513:108-113.
    PubMed     Text format     Abstract available


  30. MA TC, Le Guo, Zhou RH, Wang X, et al
    Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.
    Virology. 2017;513:91-97.
    PubMed     Text format     Abstract available


  31. DUFRASNE FE, Lucchetti M, Martin A, Andre E, et al
    Modulation of the NF-kappaB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism.
    Virology. 2017;513:11-16.
    PubMed     Text format     Abstract available


  32. YUE Y, Coskun AK, Jawanda N, Auer J, et al
    Differential interaction between human and murine Crm1 and lentiviral Rev proteins.
    Virology. 2017;513:1-10.
    PubMed     Text format     Abstract available


  33. JOSHI A, Cox EK, Sedano MJ, Punke EB, et al
    HIV-1 subtype CRF01_AE and B differ in utilization of low levels of CCR5, Maraviroc susceptibility and potential N-glycosylation sites.
    Virology. 2017;512:222-233.
    PubMed     Text format     Abstract available


    September 2017
  34. NAHABEDIAN J, Sharma A, Kaczmarek ME, Wilkerson GK, et al
    Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry.
    Virology. 2017;512:180-186.
    PubMed     Text format     Abstract available


  35. JIA M, Shaw T, Zhang X, Liu D, et al
    Decoding noises in HIV computational genotyping.
    Virology. 2017;511:249-255.
    PubMed     Text format     Abstract available


    August 2017
  36. MOLAN AM, Hanson HM, Chweya CM, Anderson BD, et al
    APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.
    Virology. 2017;511:74-81.
    PubMed     Text format     Abstract available


  37. POSTLER TS, Pantry SN, Desrosiers RC, Ghosh S, et al
    Identification and characterization of a long non-coding RNA up-regulated during HIV-1 infection.
    Virology. 2017;511:30-39.
    PubMed     Text format     Abstract available


  38. ZHANG N, Guo H, Yang J, Liu G, et al
    The poly-proline tail of SIVmac Vpx provides gain of function for resistance to a cryptic proteasome-dependent degradation pathway.
    Virology. 2017;511:23-29.
    PubMed     Text format     Abstract available


    July 2017
  39. VANCOILLIE L, Hebberecht L, Dauwe K, Demecheleer E, et al
    Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus.
    Virology. 2017;510:185-193.
    PubMed     Text format     Abstract available


  40. SCHMITT K, Mohan Kumar D, Curlin J, Remling-Mulder L, et al
    Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice.
    Virology. 2017;510:175-184.
    PubMed     Text format     Abstract available


  41. DESIMIO MG, Giuliani E, Doria M
    The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity.
    Virology. 2017;510:9-21.
    PubMed     Text format     Abstract available


  42. DAS S, Boliar S, Samal S, Ahmed S, et al
    Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505.
    Virology. 2017;510:22-28.
    PubMed     Text format     Abstract available


    June 2017
  43. VAN DEN DRIES L, Claassen MAA, Groothuismink ZMA, van Gorp E, et al
    Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls.
    Virology. 2017;509:133-139.
    PubMed     Text format     Abstract available


  44. TERRY SN, Manganaro L, Cuesta-Dominguez A, Brinzevich D, et al
    Expression of HERV-K108 envelope interferes with HIV-1 production.
    Virology. 2017;509:52-59.
    PubMed     Text format     Abstract available


    May 2017
  45. CHAND S, Messina EL, AlSalmi W, Ananthaswamy N, et al
    Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by alpha4beta7 integrin.
    Virology. 2017 May 31. pii: S0042-6822(17)30164.
    PubMed     Text format     Abstract available


  46. KIM J, Jobe O, Peachman KK, Michael NL, et al
    Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.
    Virology. 2017 May 31. pii: S0042-6822(17)30165.
    PubMed     Text format     Abstract available


  47. JACOB RA, Johnson AL, Pawlak EN, Dirk BS, et al
    The interaction between HIV-1 Nef and adaptor protein-2 reduces Nef-mediated CD4+ T cell apoptosis.
    Virology. 2017;509:1-10.
    PubMed     Text format     Abstract available


  48. BELIAKOVA-BETHELL N, Hezareh M, Wong JK, Strain MC, et al
    Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART.
    Virology. 2017;508:127-133.
    PubMed     Text format     Abstract available


  49. ESPY N, Pacheco B, Sodroski J
    Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
    Virology. 2017;508:90-107.
    PubMed     Text format     Abstract available


    April 2017
  50. MEADOR LR, Kessans SA, Kilbourne J, Kibler KV, et al
    A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.
    Virology. 2017;507:242-256.
    PubMed     Text format     Abstract available


  51. CHARLINS P, Schmitt K, Remling-Mulder L, Hogan LE, et al
    A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
    Virology. 2017;507:135-139.
    PubMed     Text format     Abstract available


    March 2017
  52. ZAPATA JC, Campilongo F, Barclay RA, DeMarino C, et al
    The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly.
    Virology. 2017;506:34-44.
    PubMed     Text format     Abstract available


  53. CROOKS ET, Osawa K, Tong T, Grimley SL, et al
    Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.
    Virology. 2017;505:193-209.
    PubMed     Text format     Abstract available


    February 2017
  54. BANERJEE S, Shi H, Banasik M, Moon H, et al
    Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Virology. 2017;505:113-126.
    PubMed     Text format     Abstract available


  55. BONAR MM, Tilton JC
    High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry.
    Virology. 2017;505:80-90.
    PubMed     Text format     Abstract available


  56. RODGERS MA, Vallari AS, Harris B, Yamaguchi J, et al
    Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon.
    Virology. 2017;504:141-151.
    PubMed     Text format     Abstract available


    January 2017
  57. ROBINSON TO, Zhang M, Ochsenbauer C, Smythies LE, et al
    CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.
    Virology. 2017;504:79-87.
    PubMed     Text format     Abstract available


  58. GEDDES VE, Jose DP, Leal FE, Nixon DF, et al
    HTLV-1 Tax activates HIV-1 transcription in latency models.
    Virology. 2017;504:45-51.
    PubMed     Text format     Abstract available


  59. FILIPPONE C, de Oliveira F, Betsem E, Schaeffer L, et al
    Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates.
    Virology. 2017;503:76-82.
    PubMed     Text format     Abstract available


  60. MIYAGI E, Kao S, Fumitaka M, Buckler-White A, et al
    Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.
    Virology. 2017;504:1-11.
    PubMed     Text format     Abstract available


  61. ZHAO G, Wu G, Lim ES, Droit L, et al
    VirusSeeker, a computational pipeline for virus discovery and virome composition analysis.
    Virology. 2017;503:21-30.
    PubMed     Text format     Abstract available


    December 2016
  62. YUAN Z, Ma F, Demers AJ, Wang D, et al
    Characterization of founder viruses in very early SIV rectal transmission.
    Virology. 2016;502:97-105.
    PubMed     Text format     Abstract available


  63. LE SAGE V, Cinti A, McCarthy S, Amorim R, et al
    Ebola virus VP35 blocks stress granule assembly.
    Virology. 2016;502:73-83.
    PubMed     Text format     Abstract available


    November 2016
  64. HU S, Neff CP, Kumar DM, Habu Y, et al
    A humanized mouse model for HIV-2 infection and efficacy testing of a single-pill triple-drug combination anti-retroviral therapy.
    Virology. 2016;501:115-118.
    PubMed     Text format     Abstract available


  65. VANWALSCAPPEL B, Rato S, Perez-Olmeda M, Diez Fuertes F, et al
    Genetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients.
    Virology. 2016;500:247-258.
    PubMed     Text format     Abstract available


  66. MOYO T, Ferreira RC, Davids R, Sonday Z, et al
    Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies.
    Virology. 2016;501:12-24.
    PubMed     Text format     Abstract available


  67. LAMICHHANE R, Mukherjee S, Smolin N, Pauszek RF 3rd, et al
    Dynamic conformational changes in the rhesus TRIM5alpha dimer dictate the potency of HIV-1 restriction.
    Virology. 2016;500:161-168.
    PubMed     Text format     Abstract available


    October 2016
  68. ASMAL M, Lane S, Tian M, Nickel G, et al
    Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections.
    Virology. 2016;499:298-312.
    PubMed     Text format     Abstract available


    September 2016
  69. MAKHDOOMI MA, Singh D, Nair Pananghat A, Lodha R, et al
    Neutralization resistant HIV-1 primary isolates from antiretroviral naive chronically infected children in India.
    Virology. 2016;499:105-113.
    PubMed     Text format     Abstract available


  70. AGOSTO LM, Hirnet JB, Michaels DH, Shaik-Dasthagirisaheb YB, et al
    Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages.
    Virology. 2016;499:72-81.
    PubMed     Text format     Abstract available


  71. SUGDEN S, Ghazawi F, MacPherson P
    HIV-1 tat protein recruits CIS to the cytoplasmic tail of CD127 to induce receptor ubiquitination and proteasomal degradation.
    Virology. 2016;498:192-200.
    PubMed     Text format     Abstract available


    August 2016
  72. WANG Y, Wang Z, Pramanik A, Santiago ML, et al
    A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction.
    Virology. 2016;498:149-163.
    PubMed     Text format     Abstract available


  73. IMLE A, Stolp B, Bohmer V, Geyer M, et al
    D186/D190 is an allele-dependent determinant of HIV-1 Nef function.
    Virology. 2016;498:44-56.
    PubMed     Text format     Abstract available


  74. KIJEWSKI SD, Akiyama H, Feizpour A, Miller CM, et al
    Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.
    Virology. 2016;497:328-336.
    PubMed     Text format     Abstract available


    July 2016
  75. ALEXANDRE KB, Mufhandu HT, London GM, Chakauya E, et al
    Progress and Perspectives on HIV-1 microbicide development.
    Virology. 2016;497:69-80.
    PubMed     Text format     Abstract available


  76. SANTOS S, Obukhov Y, Nekhai S, Pushkarsky T, et al
    Cellular minichromosome maintenance complex component 5 (MCM5) is incorporated into HIV-1 virions and modulates viral replication in the newly infected cells.
    Virology. 2016;497:11-22.
    PubMed     Text format     Abstract available


    June 2016
  77. ZHANG X, Zhou T, Frabutt DA, Zheng YH, et al
    HIV-1 Vpr increases Env expression by preventing Env from endoplasmic reticulum-associated protein degradation (ERAD).
    Virology. 2016;496:194-202.
    PubMed     Text format     Abstract available


  78. KAKISAKA M, Yamada K, Yamaji-Hasegawa A, Kobayashi T, et al
    Intrinsically disordered region of influenza A NP regulates viral genome packaging via interactions with viral RNA and host PI(4,5)P.
    Virology. 2016;496:116-126.
    PubMed     Text format     Abstract available


    May 2016
  79. JUNQUEIRA DM, Almeida SE
    HIV-1 subtype B: Traces of a pandemic.
    Virology. 2016;495:173-184.
    PubMed     Text format     Abstract available


  80. LIN YZ, Sun LK, Zhu DT, Hu Z, et al
    Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism.
    Virology. 2016;495:112-121.
    PubMed     Text format     Abstract available


  81. BONIFATI S, Daly MB, St Gelais C, Kim SH, et al
    SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells.
    Virology. 2016;495:92-100.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: